Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
British Journal of Cancer
|
March 17, 2005
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR
C Panousis, V M Rayzman, T G Johns, et al.
Cancer Research
|
June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts
F T Lee, A Rigopoulos, C Hall, et al.
The Journal of Biological Chemistry
|
October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium
B Catimel, G Ritter, S Welt, et al.
Investigational New Drugs
|
April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
Hui K Gan, Sagun Parakh, F T Lee, et al.
Cancer Research
|
June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors
A M Scott, D Geleick, M Rubira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
British Journal of Cancer
|
March 17, 2005
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR
C Panousis, V M Rayzman, T G Johns, et al.
Cancer Research
|
June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts
F T Lee, A Rigopoulos, C Hall, et al.
The Journal of Biological Chemistry
|
October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium
B Catimel, G Ritter, S Welt, et al.
Investigational New Drugs
|
April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
Hui K Gan, Sagun Parakh, F T Lee, et al.
Cancer Research
|
June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors
A M Scott, D Geleick, M Rubira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Page
of 12